<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_EPFL_Improve skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:EPFL/Improve</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV id="apta-menu-bar"><P style="float:right; color:white; padding-right:60px;padding-top:10px;" class="apta-menu-icon"><B>MENU</B></P></DIV><DIV class="apta-wrapper"><DIV class="apta-menu-item"><UL><LI class="main-submenu-item"><A href="https://2017.igem.org/Team:EPFL">Home</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Project</LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Description">Overview</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Summary">Results overview</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Outlook">Outlook</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Team</LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Team">Our team</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Attributions">Attributions</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Collaborations">Collaborations</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Human practices</LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/HP">Overview</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/HP/Mini-Kit">Educational CF Kit- Description</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/HP/Mini-Kit/Storyline">Educational CF Kit - The Project</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Lysates</LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Description/Lysates">Description</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Results/Lysates">Results</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Description/Lysates/Catalog">Catalog</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Aptamers</LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Parts/Description">Description</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Description/Aptamers">Microfluidics</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Results/Aptamers">Microfluidics - Results</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Description/Beads">Beads</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Results/Aptamers2">Beads - Results</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Toehold</LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Description/Toehold">Description</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Results/Toehold">Results- Trigger Modularity</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Results/Toehold/Signal_Generation">Results - Signal Generation</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Software</LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Software">Description</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Software/Demo">Results</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Lab</LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Safety">Safety</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Protocols">Protocols</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Notebook">Notebook</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Parts">Parts</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Medal requirements</LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Attributions">Attributions</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Collaborations">Collaborations</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Contribution">Contribution</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/HP/Silver">Silver</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/HP/Gold_Integrated">Gold Integrated</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Demonstrate">Proof of Concept</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Improve">Improvement</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Prizes</LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Engagement">Education &amp; Public Engagement</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Software">Software</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/Applied_Design">Applied Design</A></LI><LI class="sec-submenu-item"><A href="https://2017.igem.org/Team:EPFL/HP/Gold_Integrated">Integrated Human Practices</A></LI></UL></DIV><DIV class="apta-menu-item"><UL><LI class="main-submenu-item">Contact</LI><LI class="sec-submenu-item">epfl.igem2017@gmail.com</LI><LI class="sec-submenu-item"><I><A href="https://www.facebook.com/igemepfl/?fref=ts" class="fa fa-facebook fa-2x">facebook</A></I></LI><LI class="sec-submenu-item"><I><A href="https://twitter.com/epfl_igem?lang=en" class="fa fa-twitter fa-2x">twitter</A></I></LI></UL></DIV></DIV><DIV class="text-center top-space center-block" style="width:60%"><H1 class="top-space bottom-space"> Improved Parts</H1><P> Here's a list of parts we have improved in the scope of our project.
</P><H2 class="top-space bottom-space"><A href="http://parts.igem.org/Part:BBa_I732006" target="_blank"><FONT color="pink">BBa_I732006</FONT></A> - LacZalpha</H2><P>We improved the functionality of LacZalpha by modifying it in order to express LacZalpha in cell-free expression systems. On top of that we showed that <A href="https://2017.igem.org/Team:EPFL/Results/Lysates" target="_blank"><FONT color="pink">Alpha Complementation</FONT></A> could be achieved in our own E.Coli lysates. Alpha Complementation is a signaling pathway that makes use of a mutation found in certain E.Coli strains. The mutated strains contain a partial version of the LacZ gene. By adding the missing Alpha part as DNA template to a lysate reaction, a functional beta-galactosidase enzyme will be produced. Since the Alpha part has a size of 7.4% of the total LacZ gene, less resources are needed to synthesize the whole enzyme and transcription is sped up significantly. This translates into a faster and stronger colour change in our detection scheme and is thus a highly useful functionality.
</P><P>To use this part in a cell-free environment, it needed a T7 promoter, since no expression is observed if a promoter is missing. We submitted our new composite BioBrick BBa_K2203002 and it can be found <A href="http://parts.igem.org/Part:BBa_K2203002" target="_blank"><FONT color="pink">here</FONT></A>. </P><P>At the same time we added another functionality to LacZalpha : It is the reporter gene in all of the toehold switches we used for our project. Thus we have coupled the mechanism of a toehold switch to alpha complementation and shown that it works as expected in our E.Coli lysates.
</P><H2 class="top-space bottom-space"><SMALL>Incubation reactions showing alpha complementation in T7-M15 cell lysate</SMALL></H2><P>We perfromed incubation reactions at 37C of the DNA template in lysate and a no DNA control adding a colorometric substrate to detect the presence of functional beta-galactosidase: CPRG Chlorophenol red-β-D-galactopyranoside.
Below the results after 1 hour of incubation:
</P><DIV class="row"><FIGURE class="col-md-6"><FIGCAPTION>1h incubation of T7 LacZalpha in T7 M15 lysate at 37°C</FIGCAPTION></FIGURE><FIGURE class="col-md-6"><FIGCAPTION>1h incubation of no DNA control at 37°C</FIGCAPTION></FIGURE></DIV><H2 class="top-space bottom-space"><SMALL>HCV Toehold A LacZalpha in T7 M15 lysate</SMALL></H2><P> Expression of LacZalpha was measured on a plate reader. Toehold and trigger were added to a usual lysate reaction as described <A href="https://2017.igem.org/Team:EPFL/Protocols#platereader" target="_blank"><FONT color="blue">here</FONT></A>. Reactants were kept at 37°C for five hours. 
</P><CENTER><FIGURE><FIGCAPTION><CENTER>Expression of reporter gene LacZalpha within HCV Toehold A</CENTER></FIGCAPTION></FIGURE></CENTER><P> The toehold is successfully triggered and LacZalpha translated.</P><H2 class="top-space bottom-space"><A href="http://parts.igem.org/Part:BBa_J64997" target="_blank"><FONT color="pink">BBa_J64997</FONT></A> - T7 promoter</H2><P>We improved this part by composing new BioBricks that all contain the T7 promoter. This promoter is well suited for cell-free expression systems as the T7 RNA polymerase is highly specific to this region and will efficiently translate any template having this promoter in front. </P><P>We characterized this part in cell extracts from different E.Coli strains and have successfully demonstrated that all composite parts work as expected.
</P><P>The following composite parts made by us contain a T7 promoter :  BBa_K2203001, BBa_K2203002, BBa_K2203003, BBa_K2203004, BBa_K2203005, BBa_K2203006.
</P></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>